Randomized trial of recombinant platelet factor 4 versus protamine for the reversal of heparin anticoagulation in humans

Gregory J. Dehmer, Richard A. Lange, David A. Tate, Mark Pirwitz, Will Daniel, Melrose Fisher, Eric M. Bonnem

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized trial of recombinant platelet factor 4 versus protamine for the reversal of heparin anticoagulation in humans'. Together they form a unique fingerprint.

Medicine & Life Sciences